The category under the most scrutiny.
Peptides are the fastest-growing and most closely watched category in telehealth. The commercial opportunity is real and so is the regulatory exposure, and the difference between those two outcomes is almost entirely about which compounds you offer and whether a licensed provider genuinely reviews every order.
- Legally prescribable compounds only, through licensed compounding pharmacies
- Goal-based intake mapped to clinically appropriate protocols
- Provider review on every order, with no auto-approve path
- Check-ins that gate the next shipment rather than a blind rebill
How a peptide program runs
Every order is a clinical decision. In a category this scrutinised, a workflow that can be skipped is a workflow that will be examined.
Goal-based intake
Patients arrive with an objective rather than a diagnosis: energy, recovery, sleep, longevity. Intake translates that into history, medications, contraindications and consent.
Licensed provider review
A clinician licensed in the patient's state reviews every intake and selects a protocol, or declines. There is no auto-approval path in this vertical.
Compounding pharmacy fulfillment
Prescriptions route to licensed compounding pharmacies qualified for the compound and the state, cold chain where the peptide requires it.
Monitoring and check-ins
Structured check-ins on the protocol's cadence report tolerance and response back to the reviewing provider.
Check-ins gate the shipment
The next fill does not ship until the check-in is complete and the provider approves it. The clinical loop is enforced by the platform.
Category-safe storefront
Claims, imagery and copy reviewed against FTC and ad-platform standards, because this is the category where marketing language creates the exposure.
What keeps a peptide brand out of trouble
This vertical rewards discipline more than speed. Six controls do most of the work, and none of them are optional on PharmaBro.
- Only compounds that are legally prescribable through licensed compounding pharmacies appear in the catalog.
- State-by-state licensure governs provider assignment and pharmacy routing on every order.
- No research-use-only positioning anywhere in the patient experience. These are prescriptions or they are not sold.
- LegitScript certification, filed and managed at $0, which is what keeps ad accounts alive in a scrutinised category.
- A complete audit trail per patient: intake version, provider decision, prescription event, pharmacy transmission.
- Claims review on storefront copy, because FTC exposure in this category usually comes from marketing rather than medicine.
Clinical and regulatory shape of the category
| Visit type | Asynchronous review with a synchronous option, subject to state requirements. |
|---|---|
| Refill cadence | Commonly twelve-week refill cycles with an initial four-week review, depending on the compound and protocol. |
| Labs | Protocol-dependent and provider-directed rather than a universal gate. |
| Catalog discipline | Legally prescribable compounds only. No research-chemical or research-use-only positioning. |
| Marketing exposure | FTC claim substantiation is the primary risk surface in this vertical, ahead of the clinical workflow itself. |
| Common protocols | Sermorelin, NAD+, and combination wellness formulations, prescribed on clinical judgment. |
Oversight is wired in, not bolted on
Prescriptions are involved, so clinical oversight is not a setting you switch on. It is wired into the workflow, and there is no configuration in which it is absent.
Provider review the platform enforces
Nothing is prescribed until a clinician holding a licence in that patient's state signs off. There is no path through the software that reaches a pharmacy without it.
State rules in the routing layer
Which questions get asked, which clinician picks up the case and which pharmacy fills it are all decided by where the patient is sitting. Texas and California can run as different programs without you maintaining two of anything.
An audit trail you can query
Every intake version, clinical decision, script and pharmacy handoff is written to the patient record and stays queryable. When someone asks what happened in March, you answer it in a minute.
What operators ask about peptides
Only compounds that are legally prescribable through licensed compounding pharmacies and clinically appropriate for the patient. PharmaBro does not support research-use-only positioning: if a compound is offered, it is prescribed by a licensed provider and dispensed by a licensed pharmacy, or it is not in the catalog.
Build a peptide brand on compliant rails
Prescribable compounds, real provider review, check-in gated refills, and LegitScript included at no cost.